Advertisement

Impact of low tissue backscattering by optical coherence tomography on endothelial function after drug-eluting stent implantation

  • Hiroto Tamaru
  • Kenichi Fujii
  • Tsuyoshi Nakata
  • Masashi Fukunaga
  • Takahiro Imanaka
  • Kenji Kawai
  • Kojiro Miki
  • Tetsuo Horimatsu
  • Machiko Nishimura
  • Ten Saita
  • Akinori Sumiyoshi
  • Masahiko Shibuya
  • Yoshiro Naito
  • Tohru Masuyama
  • Masaharu Ishihara
Original Article
  • 18 Downloads

Abstract

This study evaluated the impact of optical coherence tomography (OCT)-derived low-backscattered tissue on mid-term coronary endothelial function after drug-eluting stent (DES) implantation. Although OCT enables detailed in vivo evaluation of neointimal tissue characterization after DES implantation, its association with physiological vascular healing response is unclear. Thirty-three stable angina pectoris patients underwent OCT examination and endothelial function testing with intracoronary infusion of incremental doses of acetylcholine 8-month after DES implantation in a single lesion of the left anterior descending artery. Neointimal tissue was classified into two patterns based on the predominant OCT light backscatter: high backscatter and low backscatter. Although the presence of uncovered or malapposed stent strut was not associated with the degree of vasoconstriction, the degree of vasoconstriction was significantly greater in the DES with low-backscattered neointima than in the DES without low-backscattered neointima (− 32.1 ± 25.7 vs. − 4.1 ± 20.1%, p = 0.003). Moreover, there was an inverse linear relationship between low backscatter tissue index and degree of vasoconstriction after acetylcholine infusion (r = 0.50 and p = 0.003). The endothelium-dependent vasomotor response after 8-month of DES was impaired in patients with low neointimal tissue backscatter on OCT imaging. OCT assessment of low-backscattered tissue may be used as surrogate markers for impairment of endothelial function after DES.

Keywords

Drug-eluting stent Endothelial function Optical coherence tomography 

Notes

Acknowledgements

The authors thank the staff in the catheterization laboratory in Hyogo College of Medicine for their excellent assistance during the study.

Compliance with ethical standards

Conflict of interest

The authors report no financial relationships or conflicts of interest regarding the content herein.

References

  1. 1.
    Iwasaki M, Otake H, Shinke T, Nakagawa M, Hariki H, Osue T, et al. Vascular responses in patients with and without diabetes mellitus after everolimus-eluting stent implantation. Circ J. 2014;78:2188–96.CrossRefPubMedGoogle Scholar
  2. 2.
    Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J. 2007;28:961–7.CrossRefPubMedGoogle Scholar
  3. 3.
    Gonzalo N, Serruys PW, Okamura T, van Beusekom HM, Garcia-Garcia HM, van Soest G, et al. Optical coherence tomography patterns of stent restenosis. Am Heart J. 2009;158:284–93.CrossRefPubMedGoogle Scholar
  4. 4.
    Tada T, Kadota K, Hosogi S, Miyake K, Amano H, Nakamura M, et al. Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: a comparison with plain old balloon angioplasty. Eur Heart J Cardiovasc Imaging. 2014;15:307–15.CrossRefPubMedGoogle Scholar
  5. 5.
    Yonetsu T, Kim JS, Kato K, Kim SJ, Xing L, Yeh RW, et al. Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography. Am J Cardiol. 2012;110:933–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Minami Y, Kaneda H, Inoue M, Ikutomi M, Morita T, Nakajima T. Endothelial dysfunction following drug-eluting stent implantation: a systematic review of the literature. Int J Cardiol. 2013;165:222–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Mitsutake Y, Ueno T, Yokoyama S, Sasaki K, Sugi Y, Toyama Y, et al. Coronary endothelial dysfunction distal to stent of first-generation drug-eluting stents. JACC Cardiovasc Interv. 2012;5:966–73.CrossRefPubMedGoogle Scholar
  8. 8.
    Fujii K, Kawasaki D, Oka K, Akahori H, Fukunaga M, Sawada H, et al. Endothelium-dependent coronary vasomotor response and neointimal coverage of zotarolimus-eluting stents 3 months after implantation. Heart. 2011;97:977–82.CrossRefPubMedGoogle Scholar
  9. 9.
    Fujii K, Masutani M, Okumura T, Kawasaki D, Akagami T, Ezumi A, et al. Frequency and predictor of coronary thin-cap fibroatheroma in patients with acute myocardial infarction and stable angina pectoris a 3-vessel optical coherence tomography study. J Am Coll Cardiol. 2008;52:787–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Kim BK, Kim JS, Park J, Ko YG, Choi D, Jang Y, et al. Comparison of optical coherence tomographic assessment between first- and second-generation drug-eluting stents. Yonsei Med J. 2012;53:524–9.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Won H, Kim JS, Shin DH, Kim BK, Ko YG, Choi D, et al. Relationship between endothelial vasomotor function and strut coverage after implantation of drug-eluting stent assessed by optical coherence tomography. Int J Cardiovasc Imaging. 2014;30:263–70.CrossRefPubMedGoogle Scholar
  12. 12.
    Takano M, Inami S, Jang IK, Yamamoto M, Murakami D, Seimiya K, et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol. 2007;99:1033–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Kim BK, Kim JS, Oh C, Ko YG, Choi D, Jang Y, et al. Major determinants for the uncovered stent struts on optical coherence tomography after drug-eluting stent implantation. Int J Cardiovasc Imaging. 2012;28:705–14.CrossRefPubMedGoogle Scholar
  14. 14.
    Vergallo R, Yonetsu T, Uemura S, Park SJ, Lee S, Kato K, et al. Correlation between degree of neointimal hyperplasia and incidence and characteristics of neoatherosclerosis as assessed by optical coherence tomography. Am J Cardiol. 2013;112:1315–21.CrossRefPubMedGoogle Scholar
  15. 15.
    Yonetsu T, Kato K, Kim SJ, Xing L, Jia H, McNulty I, et al. Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry. Circ Cardiovasc Imaging. 2012;5:660–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Konishi A, Shinke T, Otake H, Takaya T, Nakagawa M, Inoue T, et al. Favorable vessel healing after nobori biolimus A9-eluting stent implantation-6- and 12-month follow-up by optical coherence tomography. Circ J. 2014;78:1882–90.CrossRefPubMedGoogle Scholar
  17. 17.
    Lee SY, Shin DH, Mintz GS, Kim JS, Kim BK, Ko YG, et al. Optical coherence tomography-based evaluation of in-stent neoatherosclerosis in lesions with more than 50% neointimal cross-sectional area stenosis. EuroIntervention. 2013;9:945–51.CrossRefPubMedGoogle Scholar
  18. 18.
    Nagai H, Ishibashi-Ueda H, Fujii K. Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus-eluting stent restenosis. Catheter Cardiovasc Interv. 2010;75:961–3.PubMedGoogle Scholar
  19. 19.
    Nakano M, Vorpahl M, Otsuka F, Taniwaki M, Yazdani SK, Finn AV, et al. Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging. JACC Cardiovasc Imaging. 2012;5:71–82.CrossRefPubMedGoogle Scholar
  20. 20.
    Fujii K, Hao H, Masuyama T. Can optical coherence tomography findings be used as surrogates for vessel healing after drug-eluting stent implantation? Circ J. 2014;78:1826–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Murata A, Wallace-Bradley D, Tellez A, Alviar C, Aboodi M, Sheehy A, et al. Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation. JACC Cardiovasc Imaging. 2010;3:76–84.CrossRefPubMedGoogle Scholar
  22. 22.
    Hofma SH, van der Giessen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J. 2006;27:166–70.CrossRefPubMedGoogle Scholar
  23. 23.
    Kim JW, Suh SY, Choi CU, Na JO, Kim EJ, Rha SW, et al. Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent. JACC Cardiovasc Interv. 2008;1:65–71.CrossRefPubMedGoogle Scholar
  24. 24.
    Nakata T, Fujii K, Fukunaga M, Shibuya M, Kawai K, Kawasaki D, et al. Morphological, functional, and biological vascular healing response 6 months after drug-eluting stent implantation: a randomized comparison of three drug-eluting stents. Catheter Cardiovasc Interv. 2016;88:350–7.CrossRefPubMedGoogle Scholar
  25. 25.
    Tanaka N, Terashima M, Rathore S, et al. Different patterns of vascular response between patients with or without diabetes mellitus after drug-eluting stent implantation: optical coherence tomographic analysis. JACC Cardiovasc Interv. 2010;3:1074–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Nakazawa G, Shinke T, Ijichi T, et al. Comparison of vascular response between durable and biodegradable polymer-based drug-eluting stents in a porcine coronary artery model. EuroIntervention. 2014;10:717–23.CrossRefPubMedGoogle Scholar
  27. 27.
    Hoymans VY, van Dyck CJ, Haine SE, et al. Long-term vascular responses to Resolute® and Xience V® polymer-based drug-eluting stents in a rabbit model of atherosclerosis. J Interv Cardiol. 2014;27:381–90.CrossRefPubMedGoogle Scholar
  28. 28.
    Hamilos M, Sarma J, Ostojic M, et al. Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses. Circ Cardiovasc Interv. 2008;1:193–200.CrossRefPubMedGoogle Scholar
  29. 29.
    Sumida A, Gogas BD, Nagai H, et al. A comparison of drug eluting stent biocompatibility between third generation NOBORI biolimus A9-eluting stent and second generation XIENCE V everolimus-eluting stent in a porcine coronary artery model. Cardiovasc Revasc Med. 2015;16:351–7.CrossRefPubMedGoogle Scholar

Copyright information

© Japanese Association of Cardiovascular Intervention and Therapeutics 2018

Authors and Affiliations

  • Hiroto Tamaru
    • 1
  • Kenichi Fujii
    • 1
  • Tsuyoshi Nakata
    • 1
  • Masashi Fukunaga
    • 1
  • Takahiro Imanaka
    • 1
  • Kenji Kawai
    • 1
  • Kojiro Miki
    • 1
  • Tetsuo Horimatsu
    • 1
  • Machiko Nishimura
    • 1
  • Ten Saita
    • 1
  • Akinori Sumiyoshi
    • 1
  • Masahiko Shibuya
    • 1
  • Yoshiro Naito
    • 1
  • Tohru Masuyama
    • 1
  • Masaharu Ishihara
    • 1
  1. 1.Division of Cardiovascular Medicine and Coronary Heart DiseaseHyogo College of MedicineNishinomiyaJapan

Personalised recommendations